Drug Information Association Logo

22nd Annual Phama Marketing Conference

Horsham, PA, USA — Jan 11, 2010

The Drug Information Association (DIA) will host the 22nd Annual Conference on Marketing Pharmaceuticals Integrated Marketing, Emerging Media Trends, and New Regulations from February 22-24 in New York, NY.

This annual pharma marketing conference will provide insight into emerging media trends and how they impact FDA enforcement actions. Experts from industry and FDA will discuss the evolution of the regulatory and legal environment and how this new environment impacts the marketing of biopharmaceuticals and related products. Session topics will include:

  • Enforcement by the three centers within FDA that regulate drugs
  • Biological products and veterinary drugs
  • Direct-to-consumer advertising
  • State regulations
  • Oversight of off-label issues by the Office of Inspector General and Department of Justice
  • Latest innovations in the use of the internet for product
  • Communication

Rachel E. Behrman, MD, MPH, Deputy Director, Office of Medical Policy; Associate Commissioner for Clinical Programs, will deliver a keynote address the future initiatives of the Office of Medical Policy.

A half-day pre-conference tutorial, DDMAC and Compliance 101: A Primer, will take place on February 22.






ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.